Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Bayer plc, 400 South Oak Way, Reading, RG2 6AD
Cyprostat 50 mg.
| Pharmaceutical Form |
|---|
|
Tablet. White, round tablet, scored on one side and embossed with the letters “BV” in a regular hexagon on the other side. |
Each white, scored tablet contains 50 mg cyproterone acetate.
Excipient with known effect: lactose 108.75 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cyproterone |
Cyproterone acetate acts as an antiandrogen by blocking androgen receptors. It also has progestogenic activity, which exerts a negative feedback effect on hypothalamic receptors, so leading to a reduction in gonadotrophin release, and hence to diminished production of testicular androgens. Sexual drive and potency are reduced and gonadal function is inhibited. |
| List of Excipients |
|---|
|
Maize starch |
Original packs containing 160 tablets (16 blister strips of 10 tablets), 80 tablets (8 blister strips of 10 tablets) or 60 tablets (6 blister strips of 10 tablets).
Bayer plc, 400 South Oak Way, Reading, RG2 6AD
PL 00010/0525
Date of first authorisation: 01 May 2008
Date of Renewal of the Authorisation: 08 August 2003
| Drug | Countries | |
|---|---|---|
| CYPROSTAT | Australia, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
